Table 1 Comparison of clinical data within the study population

Age of the women, y^a

30.9 ± 5.8

32.2 ± 4.5

0.06

WBC, 10³/μL^a

10.4 ± 2.4

10.6 ± 2.2

0.41

RBC, 10⁶/μL^d

4.1 (3.7–4.5)

4.24.0–4.4)

0.33

HB, g/dL^a

12.4 ± 2.2

12.4 ± 1.1

0.98

HCT, %^a

35.5 ± 3.4

36.2 ± 2.7

0.11

MCV, fL^a

85.3 ± 6.4

87.0 ± 5.1

0.04^c

MCHC, g/dL^a

34.3 ± 2.1

33.8 ± 1.6

0.08

PLT, 10³/μL^a

198.5 ± 64.6

223.7 ± 55.5

0.00^c

BMI, kg/m^2a

26.4 ± 3.1

24.7 ± 3.6

0.00^c

Week of gestation Early PE (n = 39) vs controls

32 (30–33)

39 (38–39)

0.00 ^c

Week of gestation Late PE (n = 63) vs controls

38 (37–39)

39 (38–39)

0.01 ^c

Weight of the newborn, g^a

2409.9 ± 938.3

3409.2 ± 433.0

0.00^c

Height of the newborn, cm^a

48.3 ± 6.6

54.5 ± 2.8

0.00^c

Apgar score, 1 min^a

8.6 ± 1.6

9.5 ± 0.8

0.00^c

Primiparas, n %^b

69 (68%)

37 (36%)

0.00^c

Miscarriages, n %^b

19 (19%)

21 (20%)

0.75

Baby sex (male), n %^b

60 (59%)

47 (46%)

0.06